METHOD OF DETERMINING OUTCOME OF NON SMALL-CELL LUNG CANCER ACCORDING TO XRCC3 POLYMORPHISM

摘要

Method for determining a platinum-based chemotherapeutic regimen for treating Non-Small-Cell Lung cancer (NSCLC) in a patient comprising: a) determining the presence or absence of the XRCC3 MetMet polymorphism in a biological sample from the patient, c) determining a a platinum-based chemotherapeutic regimen based on the presence or absence of the XRCC3 MetMet polymorphism in the sample.